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Abstract  
Context: Due to their availability and rapid turnaround time, the supplemental role of chest computed 
tomography (CT) scan and real-time polymerase chain reaction (RT-PCR) is growing for early diagnosis of 
patients with COVID-19. However, due to the low efficiency of viral nucleic acid detection as well as low 
specificity of chest CT scan for detecting COVID-19 pneumonia, both methods show incomplete clinical 
performance for proper COVID-19 disease diagnosis. The purpose of this review was to compare the clinical 
performance of two methods and to evaluate the diagnostic values of chest CT scan and RT-PCR for suspected 
COVID-19 patients. 
Evidence acquisition: We systemically searched PubMed, Cochrane, from December 2019 to the end of 
April 2020. Clinical research papers in goal fields that reviewed COVID-19 patients, whom chest CT scan, 
and PCR testing were performed together were included. 
Results: In total, we found 536 studies; and finally168 studies were shortlisted. Following title and abstract 
screening, we reached 83 studies based on the inclusion and exclusion criteria. Conducted screen by the full 
text covered 28 studies, which led to data extraction. By the full-text assessment of 28 included studies, we 
found 4486 assessed patients. Totally, 3164 patients had positive chest CT scans, and 3014 patients had 
positive PCR results. The finding showed that recent studies on the diagnostic performance of RT-PCR and 
chest CT scan have commonly been reported from China. 
Conclusion: The results from this review indicate that the chest CT scan should be used for symptomatic 
and hospitalized patients. Moreover, chest CT scan should not be used as a primary screening tool for 
diagnosing COVID-19. Application of RT-PCR as the first line diagnosis is still recommended. 
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CONTEXT
Since December 2019, a cluster of pneumonia cases 
caused by a novel coronavirus named COVID-19 
originating in Wuhan City, China, has spread to 
more than 200 countries globally, with prolonged 
human-to-human transmission. Subsequently, it 
has alarmed as a public health emergency of 
international concern (1). The clinical spectrum of 
COVID-19 ranged from either asymptomatic or 
mild to moderate respiratory infection to severe 
cases who were rapidly developing acute 
respiratory distress syndrome (ARDS) or multi-
organ failure resulting in fatal outcomes (2-4). 
Therefore, the early diagnosis for both 
asymptomatic and symptomatic cases is of 
paramount importance for the management of 
patients as well as for infection control 
measurements to mitigate the transmission to 
other members of society. Currently, the gold-
standard method for the diagnosis of COVID-19 is a 
positive polymerase chain reaction (PCR)-based 
viral ribonucleic acid (RNA) detection, which is also 
helpful for discharging patients from isolation (2). In 
addition, recent studies explored that COVID-19 
pneumonia has typical chest computed 
tomography (CT) scan characteristics with 
subsequent time-course features (5-8). Therefore, 
chest CT scan has become a routine tool for 
detection, diagnosis, and monitoring of COVID-19 
pneumonia in both symptomatic and 
asymptomatic cases. However, both diagnostic 
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methods have shown to suffer from some 
limitations. A proportion of false-negative results 
have been reported for Reverse transcription-
polymerase chain reaction (RT-PCR) for COVID-19 
(9-11). The explanation for the low efficiency of viral 
nucleic acid detection may include the following.  
Inappropriate sampling (improper clinical 
sampling, different levels of viral load at the time of 
examination, etc.), technical issues (immature 
development of nucleic acid detection technology 
for COVID-19, the risk of primer/probe mismatch 
due to the high mutation rate of the virus, etc.) and 
the lack of standardization and validation 
processes across different laboratories and 
hospitals. On the other hand, the attributable 
features of COVID-19 pneumonia on the chest CT 
scan, such as ground-glass opacity (GGO) or 
bilateral involvement, are nonspecific and could be 
observed in other viral pneumonia (5, 12). Therefore, 
the diagnostic utility of chest CT scan in a clinical 
setting, especially where the occurrence of COVID-
19 pneumonia is lower than that of other 
respiratory diseases, is still unidentified (13). These 
problems can potentially contribute to the delay in 
the effective diagnosis and monitoring of the 
patients and preventive quarantine. Consequently, 
some experts suggest that the application of 
clinical, imaging and laboratory procedures is 
necessary for confirmation of the final diagnosis 
(11). We, therefore, aimed to analyze the published 
scientific literature concerning the comparison 
between the diagnostic values of chest CT scan 
compared with RT-PCR testing and to better 
understand their usefulness for proper diagnosis of 
COVID-19.  
EVIDENCE ACQUISITION 
Search strategy 
We systemically searched PubMed, Cochrane, from 
December 2019 to the end of April 2020. Our 
search was restricted to original articles in the 
English language. In the search strategy for 
searching “Diagnostic Performance of Chest CT 
scan versus Real-Time PCR for COVID-19 patients”; 
we used the following keywords and medical 
subject headings (MeSH): “SARS-CoV-2” OR “severe 
acute respiratory syndrome coronavirus 2“ OR 
“SARS Coronavirus-2” OR “Novel Coronavirus 
2019” OR “COVID-19” OR “Coronavirus disease 
2019” AND “PCR” OR “Molecular detection” OR 
“Molecular diagnosis” OR “RT-PCR” OR “Real time-
PCR” AND “CT scan” OR “Imaging techniques” OR 
“Chest radiology.” Two independent researchers 
performed the search, and results were triple 
checked by a third researcher.  
Inclusion criteria 
Clinical research papers in goal fields that reviewed 
COVID-19 patients, whom chest CT scan, and PCR 
testing were performed together were included. 
Articles published, in a peer-reviewed journal, 
articles indexed in Medline during December 2019 
to the end of April 2020 included in this review. 
Exclusion criteria 
Articles, which reported patients who went under 
CT scan only or PCR testing separate, in vitro 
studies, literature reviews (The literature reviews 
were checked for relevant citations), papers 
published in a language other than English, and 
case reports articles were excluded. Personal 
communication and letter to the editor with 
relevant experts were also dismissed. 
Data extraction and quality assessment 
Data included author name, sample size, CT scan 
results, PCR results, and main finding of studies. In 
order to evaluate the quality of screened studies, 
data extraction, and study quality assessment were 
performed independently by two reviewers, and 
the third researcher resolved conflict cases. 
RESULTS 
In total, we found 536 studies published from 
December 2019 to the end of April 2020 by the 
advanced search strategy on PubMed and 
Cochrane. Finally, after the exclusion of duplicates, 
168 studies were shortlisted. Following title and 
abstract screening, we reached 83 studies based on 
the inclusion and exclusion criteria. Conducted 
screen by the full text covered 28 studies, which led 
to data extraction (Figure 1). The data extraction 
 
Figure 1: Flow chart of studies selection 
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procedure is shown in table 1. By the full-text 
assessment of 28 included studies, we found 4486 
assessed patients. Totally, 3164 patients had 
positive chest CT scans, and 3014 patients had 
positive PCR results. The finding showed that 
recent studies on the diagnostic performance of 
RT-PCR and chest CT scan have commonly been 
reported from China. Results indicated that the 
number of studies from China was higher than the 
other five countries we analyzed in this study. Our 
results in this review indicated that chest CT scan 
should be used for symptomatic and hospitalized 
patients. However, chest CT scan should not be 
used as a primary screening tool for diagnosing 
COVID-19. Application of RT-PCR as the first line 
diagnosis is still recommended.  
DISCUSSION 
Since the recognition of the SARS-CoV-2 virus in 
late December 2019, more than 4 million people 
are known to have been infected. SARS-CoV-2 
causes COVID-19, which has been led to over 
250,000 deaths worldwide so far (15). At the 
moment, in the lack of specific vaccines or 
therapeutic drugs against COVID-19, it is crucial to 
diagnose the disease at the early stage and 
immediately isolate infected patients from the 
healthy population.  
According to the latest guidelines released by the 
Chinese government, the key indicator for the 
confirmation of the diagnosis of COVID-19 is based 
on RT-PCR or sequencing of the gene for 
respiratory or blood specimens (10); however, there 
are some limitations in collection and 
transportation of samples and also the kit 
performance. Chest CT scan is a common imaging 
tool for pneumonia diagnosis; it is relatively easy to 
perform and fast (16). The initial diagnosis of COVID-
19 is essential for infection control and treatment 
of disease. In the epidemic area, chest CT scan in 
comparison with RT-PCR, maybe a more reliable, 
practical, and rapid method to diagnose COVID-19 
(10). On the other hand, in terms of RT-PCR as a gold 
standard method for COVID-19 diagnosis, we still 
believe in its application as the first line diagnosis. 
However, a rate of 10-40% RT-PCR false-negative 
results made this technique insufficient for proper 
detection. A major obstacle for this low efficacy 
might be related to sampling errors, markedly 
inappropriate timing of sampling, which is 
reflected by variations in viral load in upper versus 
lower respiratory tract. Wang et al. showed that 
SARS-CoV-2 viral load increased in sputum similar 
to levels in the throat and nasopharyngeal swabs in 
Table 1: Comparison of clinical performance of chest CT scan versus Real Time PCR from available studies 
No. Author Sample Size 
Positive Chest CT scan Positive RT-PCR test 
n (%) 
1 Ai et al. (10) 1014 888 (87.6) 601 (59.3) 
2 Caruso et al. (27) 158 102 (64.6) 62 (39.2) 
3 Chen J et al. (28) 249 163 (65.7) 248 (99.6) 
4 Chen N et al. (29) 99 99 (100) 99 (100) 
5 Chen Y et al. (30) 42 40 (95.2) 28 (66.7) 
6 Cheng  et al. (31) 33 31 (93.9)  11 (33.3) 
7 Fang et al. (11) 51 50 (98.0) 36 (70.5) 
8 Himoto et al. (13) 21 211 (100) 6 (28.5) 
9 Huang C et al. (32) 59 41 (69.4) 41 (69.4) 
10 Huang G et al. (33) 30 25 (83.3) 30 (100) 
11 Kim et al. (34) 28 13 (46.4) 28 (100) 
12 Lei et al. (35) 14 10 (71.4) 14 (100) 
13 Xu et al. (36) 90 69 (76.6) 90 (100) 
14 Young et al. (37) 18 6 (33.3) 18 (100) 
15 To et al. (38) 23 15 (65.2) 23 (100) 
16 Wang et al. (39) 1012 917 (90.6) 1012 (100) 
17 Wu et al. (40) 80 55 (68.8) 80 (100) 
18 Shi et al. (41) 81 81 (100) 81 (100) 
19 Long et al. (42) 36 35 (97.2) 30 (83.3) 
20 Pan et al. (6) 21 17 (80.9) 21 (100) 
21 Yang et al. (43) 149 132 (88.5) 149 (100) 
22 Zhao et al. (44) 34 19 (55.9) 19 (55.9) 
23 Xie C et al. (45) 19 17 (89.5) 9 (47.4) 
24 Su et al. (46) 23 14 (60.8) 23 (100) 
25 Xie, X et al. (9) 167 160 (95.8) 162 (97.0) 
26 Sun et al. (47) 788 104 (13.2) 54 (6.9) 
27 Albano et al. (48) 65 6 (9.2) 5 (7.7) 
28 He et al. (49) 82  28 (34.1) 34 (41.5) 
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the early stage of the disease (17). Recent studies 
also reported that testing of different types of 
specimens from multiple sites might reduce false-
negative and improve the sensitivity test results (17, 
19). Moreover, in late post-infection days, the viral 
load levels were still higher than that of upper 
respiratory tract specimens. These results 
indicated complicated viral kinetics in the 
respiratory tract of patients, making the choice of 
specimens more puzzling. In a retrospective study, 
Ai et al. analyzed 1014 hospitalized patients with 
suspected COVID-19 in Wuhan, China with patients 
undergoing both serial RT-PCR testing and chest 
CT scan; they showed that chest CT has higher 
sensitivity for the diagnosis of COVID-19 as 
compared with initial RT-PCR from pharyngeal 
swab samples (2). In a study, medical data from 
1099 hospitalized patients and outpatients with 
laboratory-confirmed COVID-19 were analyzed. 
Confirmed cases of COVID-19 were defined as a 
positive result on real-time RT-PCR assay of nasal 
and pharyngeal swab specimens; however, chest 
CT scan findings suggested infection in 86% (n = 
840) of patients. Positive CT findings included 
ground-glass opacity, patchy local shadowing, 
bilateral patchy shadowing, or interstitial 
abnormalities. Additionally, in 17.9% (n=157) of 
patients with non-severe disease and in 2.9% (n=5) 
of patients with severe disease did not observe 
radiographic or CT abnormality (18). A study 
reported that the Chest CT test is essential to avoid 
COVID-19 missed diagnosis due to false-negative 
RT-PCR (20). Chinese guidelines recommended that 
suspected COVID-19 patients with negative RT-
PCR tests should re-tested 24 hours later. Patients 
can be discharged from the hospital after two 
consecutive negative RT-PCR tests and with no 
suspicion or clinical manifestation of the disease 
(21).  
World Health Organization (WHO) advises the 
lower respiratory tract samples (expectorated 
sputum, endotracheal aspirate, or bronchoalveolar 
lavage in ventilated patients) for patients who 
showed negative upper respiratory sample 
(nasopharyngeal /oropharyngeal swabs) PCR 
results (22). Screening and monitoring of patient 
conditions in Italy and China are performed by 
Chest CT scan alongside RT-PCR (22, 23). Screening 
criteria including fever, chest CT scan 
abnormalities, reduced white cell, or lymphocyte 
counts for diagnosing of COVID-19; individuals 
with these criteria for confirmation of COVID-19 
would be tested by RT-PCR (24). WHO suggests chest 
CT scan for the patient with severe pneumonia (21, 
25). American College of Radiology, American 
Society of Emergency Radiology and the Society of 
Thoracic Radiology recommended that chest CT 
scans are not recommended as a first-line test to 
diagnose COVID-19 (14). Kings College Hospital 
guidelines reported that chest CT scan has higher 
sensitivity in the early stage of COVID-19 disease 
than RT-PCR test, and chest CT scan abnormalities 
may appear before PCR positivity; however, some 
studies have not shown this pattern (26). 
CONCLUSIONS 
The results from this review indicate that the chest 
CT scan should be used for symptomatic and 
hospitalized patients. Moreover, chest CT scan 
should not be used as a primary screening tool for 
diagnosing COVID-19. A proportion of COVID-19 
patients show false-negative RT-PCR results. 
Therefore, we recommend careful respiratory tract 
sampling and considering the appropriate timing 
and correct anatomical site (in relation to viral 
kinetics in individual patients) to avoid false-
negative detection outcomes. In brief, for moderate 
to severe as well as hospitalized COVID-19 patients, 
a synergy of both methods is recommended. 
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